Ophthalmic Drugs: World Market Prospects 2012-2022Visiongain
March 16, 2012
183 Pages - SKU: VSG3871639
6.2.3 Lucentis Sales Forecast, 2012-2022
Lucentis dominated the market in 2010 and 2011, owing to its reportedly superior efficacy over competitor treatments. Total revenues were $2935m in 2010 and $3707m in 2011 compared with $2338m in 2009. Nevertheless, visiongain predicts that there is scope for further growth, and that revenues will increase from 2012 to 2016. The major drivers for this growth will be the rapidly- increasing prevalence of AMD worldwide, combined with the likely expansion of approved indications to include treatment of DR.
American Academy of Ophthalmology (AAO) [US]
American Society of Retina Specialists (ASRS) [US]
Association for Research in Vision and Ophthalmology
Bausch & Lomb
Chugai Pharmaceutical Corp.
European Medicines Agency (EMEA/EMA)
Food and Drug Administration (FDA) [US]
Galderma International SA (Nestlé and L'Oréal)
Johnson & Johnson
Kyorin Pharmaceutical Co.
Kyowa Hakko Kirin Corp.
Merck & Co.
Ministry of Health, Labour and Welfare [Japan]
Moorfields Eye Hospital [UK]
National Eye Institute (NEI) [US]
National Health Service (NHS) [UK]
National Institute for Health and Clinical Excellence (NICE) [UK]
National Institutes of Health (NIH) [US]
Otsuka Pharmaceutical Corp.
Oxford Eye Hospital [UK]
Rutgers University, Springfield, New Jersey [US]
Santen Pharmaceutical Corp.
Sanwa Kagaku Kenkyusho Corp.
Teva Pharmaceutical Industries
University College of London (UCL), Institute of Ophthalmology [UK]
University of Aston, Birmingham [UK]
University of Oxford [UK]
More Ophthalmology reports by Visiongain
Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2011-2021 by Visiongain
What are the commercial prospects for the treatment of macular degeneration (AMD) and diabetic retinopathy (DR)? Our new report shows you potential revenues to 2021, ...
Ophthalmic Drugs: World Market 2011-2021 by VisiongainSee all reports like this >>
Where will the highest revenue growth occur in the ophthalmic drug market? Our new report shows you the eye disorder treatment market's potential from 2011 ...
More Global Ophthalmology reports
Global Eye Care Surgical Market 2012-2016 by Infiniti Research Limited
Global Eye Care Surgical Market 2012-2016TechNavio's analysts forecast the Global Eye Care Surgical market to grow at a CAGR of 8.54 percent over the period ...
Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] – Global Forecasts to 2017 by MarketsandMarkets
A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems. It traces ...
Open-Angle Glaucoma Global Clinical Trials Review, H1, 2013 by GlobalData
Open-Angle Glaucoma Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, H1, 2013 provides data on the Open-Angle Glaucoma ...
Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018 by WinterGreen ResearchSee all reports like this >>
WinterGreen Research announces that it has published a new study Intraocular Lens (IOL) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018. The 2013 study ...
We can help you find what you need. Call us or write us:
Need help in your search?